J. Kitajima et al. / Phytochemistry 65 (2004) 3279–3287
3285
H-8/C-3, C-4, C-5, C-9, C-10; H3-9/C-4, C-8, C-10; H3-
10/C-4, C-8, C-9; Glc H-1/C-1.
C-8, C-10; H3-10/C-4, C-8, C-9; Glc H-1/C-1; Glc H-2/
OCOCH3; OCOCH3/OCOCH3.
3.10. Alkaline hydrolysis of 4
3.6. Enzymatic hydrolysis of 2
Glucoside 4 (2 mg) was deacetylated in the same way
as described for 3 to afford 2 (1 mg).
A mixture of 2 (100 mg) and b-glucosidase (5 mg,
Toyobo Co. Ltd., Lot 52275) in water (5 ml) was shaken
in a water bath at 37 ꢁC for 15 d. The mixture was con-
centrated in vacuo to dryness and the residue was sub-
jected to silica gel CC [CHCl3–MeOH (9:1 ! 1:1)] to
afford 1 (45 mg) and a sugar fraction. The sugar fraction
was passed through Sephadex LH-20 (MeOH) to give a
syrup, and HPLC [carbohydrate analysis (Waters),
detector; JASCO RI-930 detector and JASCO OR-990
chiral detector, solv.; MeCN–H2O (17:3), 2 ml/min; t
3.11. Thymuside A (5)
22
Amorphous powder, ½aꢀ ¼ þ2ꢂ (c = 0.5, MeOH).
D
Positive FAB-MS m/z: 353.1565 [M + Na]+ (Calcd for
C16H26NaO7; 353.1577), 313 [M ꢁ H2O + H]+ (base),
135 [M ꢁ C6H12O6 + H]+. Negative FABMS m/z: 329
[M ꢁ H]+
(base),
311
[M ꢁ H2O ꢁ H]+,
293
[M ꢁ 2H2OH]+. For H NMR and 13C NMR spectral
data, see Tables 1 and 3. HMBC correlations: H-2ax/
C-1, C-3, C-6, C-7, Sug C-2; H-3ax/C-1, C-2, C-4, C-5;
H-3eq/C-1, C-2, C-4, C-5; H-5/C-1, C-3, C-6, C-8;
H-6ax/C-1, C-4, C-5; H-6eq/C-1, C-2, C-4, C-5, C-7;
H3-7/C-1, C-2, C-6; H-8/C-3, C-4, C-5, C-9, C-10; H3-
9/C-4, C-8, C-10; H3-10/C-4, C-8, C-9; Sug H-1/C-1,
Sug C-2, Sug C-5; Sug H-3/Sug C-2, Sug C-4, Sug C-
5; Sug H-4/Sug C-3, Sug C-5, Sug C-6; Sug H-5/Sug
C-1, Sug C-3, Sug C-4, Sug C-6; Sug H2-6/Sug C-4,
Sug C-5. NOE correlations: H-2ax/H-6ax; H-3ax/H3-7,
H3-10; H-3eq/H3-10; H-5/H-8, H3-9; H-6eq/H3-7; Sug
H-1/Sug H-3, Sug H-5; Sug H-3/Sug H-5.
1
R 4.50 min (same location as that of
lished the presence of -glucose.
D-glucose)] estab-
D
3.7. (1R,2R)-p-menth-4(5)-ene-1,2-diol 1-O-b-
acetyl) glucopyranoside (3)
D-(6-O-
24
Amorphous powder, ½aꢀ ¼ ꢁ38ꢂ (c = 0.4, MeOH).
D
IRmmax nujol cmꢁ1: 3350 (OH), 1720 (acetoxyl). Positive
FAB-MS m/z: 397 [M + Na]+, 375.2029 [M + H]+
(Calcd for C18H31O8; 375.2019), 153 [M ꢁ C8H14O7 +
1
H]+ (base). For H NMR and 13C NMR spectral data,
see Tables 1 and 3. HMBC correlations: H-2ax/C-1, C-
6, C-7; H-3ax/C-1, C-2, C-4, C-5, C-8; H-3eq/C-1, C-2,
C-4, C-5, C-8; H-5/C-1, C-3, C-4, C-6, C-8; H-6ax/C-1,
C-2, C-4, C-5, C-7; H-6eq/C-1, C-2, C-4, C-5, C-7; H3-
7/C-1, C-2; H-8/C-3, C-4, C-5, C-9, C-10; H3-9/C-4, C-
8, C-10; H3-10/C-4, C-8, C-9; Glc H-1/C-1; Glc H-6a/
OCOCH3; Glc H-6b/OCOCH3; OCOCH3/OCOCH3.
3.12. (1R,2R)-p-menth-3-ene-1,2-diol 2-O-b-
glucopyranoside (6)
D-
22
Amorphous powder, ½aꢀ ¼ ꢁ23ꢂ (c = 1.7, MeOH).
D
Positive FAB-MS m/z: 371.1484 [M + K]+ (Calcd for
C16H28KO7; 371.1472), 355.1746 [M + Na]+ (Calcd for
C16H28NaO7; 355.1733), 153 [M ꢁ C6H12O6 + H]+
3.8. Alkaline hydrolysis of 3
1
(base). For H NMR (in pyridine-d5), see Table 1; (in
Glucoside 3 (5 mg) was deacetylated by heating in a
water bath with 5% NH4OH–MeOH for 6 hr. Glucoside
2 (3 mg) was obtained after Sephadex LH-20 (MeOH)
column chromatography.
CD3OD): 1.02 (6H, s, H3-9 and H3-10), 1.19 (3H, s,
H3-7), 1.73 (1H, ddd, J = 5.0, 10.5, 13.0 Hz, H-6ax),
1.88 (1H, ddd, J = 3.0, 5.0, 13.0 Hz, H-6eq), 2.09 (1H,
ddd, J = 3.0, 10.5, 17.0 Hz, H-5ax), 2.11 (1H, ddd,
J = 5.0, 5.0, 17.0 Hz, H-5eq), 2.21 (1H, septet. J = 7.0,
H-8), 4.28 (1H, br s, H-2ax), 5.22 (1H, br s, H-3), 4.58
(1H, d, J = 7.5 Hz, Glc H-1). For 13C NMR (in pyri-
dine-d5), see Table 3; (in CD3OD): 80.85 (C-1), 74.18
(C-2), 122.56 (C-3), 145.92 (C-4), 25.98 (C-5), 33.73
(C-6), 16.62 (C-7), 35.35 (C-8), 21.70, 21.87 (C-9, C-
10), 98.03 (Glc C-1), 75.29 (Glc C-2), 78.15 (Glc C-3),
71.94 (Glc C-4), 77.71 (Glc C-5), 62.85 (Glc C-6).
HMBC correlations: H-2ax/ C-1, C-3, C-4, C-7; H-3/
C-1, C-5, C-8; H-5ax/C-1, C-3, C-4, C-6; H-5eq/C-1,
C-3, C-4, C-6; H-6ax/C-1, C-2, C-4, C-5, C-7; H-6eq/
C-1, C-2, C-4, C-5, C-7; H3-7/C-1, C-2, C-6; H-8/C-3,
C-4, C-5, C-9, C-10; H3-9/C-4, C-8, C-10; H3-10/C-4,
C-8, C-9; Glc H-1/C-1. NOE correlations:
3.9. (1R,2R)-p-Menth-4(5)-ene-1,2-diol 1-O-b-
acetyl) glucopyranoside (4)
D-(2-O-
22
Amorphous powder, ½aꢀ ¼ ꢁ32ꢂ (c = 0.4, MeOH).
D
IRmmax cmꢁ1: 3350 (OH), 1720 (acetoxyl). Positive
FAB-MS m/z: 397 [M + Na]+, 375.2002 [M + H]+
(Calcd for C18H31O8; 375.2019), 153 [M ꢁ C8H14O7 +
1
H]+ (base). For H NMR and 13C NMR spectral data,
see Tables 1 and 3. HMBC correlations: H-2ax/C-1, C-
3, C-4, C-6, C-7; H-3ax/C-2, C-4, C-5, C-8; H-3eq/C-1,
C-2, C-4, C-5; H-5/C-1, C-3, C-6, C-8; H-6ax/C-1, C-2,
C-4, C-5, C-7; H-6eq/C-1, C-2, C-4, C-5, C-7; H3-7/C-
1, C-2, C-6; H-8/C-3, C-4, C-5, C-9, C-10; H3-9/C-4,